Association between psoriasis and leisure-time physical activity: Findings from the National Health and Nutrition Examination Survey

Journal of Dermatology

Volumn 42, Issue 2, 2015, Pages 148-153

  Do, Young Kyung ^a   Lakhani, Naheed ^b   Malhotra, Rahul ^c   Halstater, Brian ^d   Theng, Colin ^e   Østbye, Truls ^c,d  

^a Seoul National University College of Medicine   (South Korea)

^b EMORY UNIVERSITY   (United States)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e NATIONAL SKIN CENTRE   (Singapore)

Author keywords

cardiometabolic risk; epidemiology; physical activity; psoriasis; public health

Indexed keywords

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MALE; METABOLIC EQUIVALENT; PHYSICAL ACTIVITY; PSORIASIS; QUESTIONNAIRE; SKIN DEFECT; UNITED STATES; EXERCISE; NUTRITION; PHYSIOLOGY; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; EXERCISE; HUMANS; LEISURE ACTIVITIES; METABOLIC EQUIVALENT; NUTRITION SURVEYS; PHYSICAL EXERTION; PSORIASIS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84922692808     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.12721     Document Type: Article

References (46)

1. Langley RG, Krueger GG, Griffiths CE,. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64 (Suppl 2): ii18-ii23 discussion ii4-5.
2. Raho G, Koleva DM, Garattini L, et al,. The burden of moderate to severe psoriasis: an overview. Pharmacoeconomics 2012; 30: 1005-1013.
3. Burch PR, Rowell NR,. Mode of inheritance in psoriasis. Arch Dermatol 1981; 117: 251-252.
4. Ferrandiz C, Pujol RM, Garcia-Patos V, et al,. Psoriasis of early and late onset: a clinical and epidemiologic study from Spain. J Am Acad Dermatol 2002; 46: 867-873.
5. Henseler T, Christophers E,. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13: 450-456.
6. Love TJ, Qureshi AA, Karlson EW, et al,. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006. Arch Dermatol 2011; 147: 419-424.
7. Azfar RS, Gelfand JM,. Psoriasis and metabolic disease: epidemiology and pathophysiology. Curr Opin Rheumatol 2008; 20: 416-422.
8. Takahashi H, Iizuka H,. Psoriasis and metabolic syndrome. J Dermatol 2012; 39: 212-218.
9. Shikiar R, Heffernan M, Langley RG, et al,. Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: patient-reported outcomes from a phase II randomized controlled trial. J Dermatolog Treat 2007; 18: 25-31.
10. Choi J, Koo JY,. Quality of life issues in psoriasis. J Am Acad Dermatol 2003; 49: S57-S61.
11. Ramsay B, O'Reagan M,. A survey of the social and psychological effects of psoriasis. Br J Dermatol 1988; 118: 195-201.
12. Dubertret L, Mrowietz U, Ranki A, et al,. European patient perspectives on the impact of psoriasis: the EUROPSO patient membership survey. Br J Dermatol 2006; 155: 729-736.
13. Jenner N, Campbell J, Plunkett A, et al,. Cost of psoriasis: a study on the morbidity and financial effects of having psoriasis in Australia. Australas J Dermatol 2002; 43: 255-261.
14. Manjula VD, Sreekiran S, Saril PS, et al,. A study of psoriasis and quality of life in a tertiary care teaching hospital of kottayam, Kerala. Indian J Dermatol 2011; 56: 403-406.
15. Leibowitz E, Seidman DS, Laor A, et al,. Are psoriatic patients at risk of heat intolerance? Br J Dermatol 1991; 124: 439-442.
16. Wilson FC, Icen M, Crowson CS, et al,. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a population-based study. Arthritis Rheum 2009; 61: 233-239.
17. Shih M, Hootman JM, Kruger J, et al,. Physical activity in men and women with arthritis National Health Interview Survey, 2002. Am J Prev Med 2006; 30: 385-393.
18. Yosipovitch G, Goon A, Wee J, et al,. The prevalence and clinical characteristics of pruritus among patients with extensive psoriasis. Br J Dermatol 2000; 143: 969-973.
19. Amatya B, Wennersten G, Nordlind K,. Patients' perspective of pruritus in chronic plaque psoriasis: a questionnaire-based study. J Eur Acad Dermatol Venereol 2008; 22: 822-826.
20. Wilson PB, Bohjanen KA, Ingraham SJ, et al,. Psoriasis and physical activity: a review. J Eur Acad Dermatol Venereol 2012; 26: 1345-1353.
21. Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey. Available at: http://www.cdc.gov/nchs/nhanes.htm
22. Centers for Disease Control and Prevention (CDC). Analytic and reporting guidelines. The National Health and Nutrition Examination Survey (NHANES). Available at: http://www.cdc.gov/nchs/data/nhanes/nhanes-03-04/nhanes-analytic-guidelines-dec-2005.pdf
23. Ainsworth BE, Haskell WL, Whitt MC, et al,. Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 2000; 32: S498-S504.
24. Tucker JM, Welk GJ, Beyler NK,. Physical activity in US: adults compliance with the Physical Activity Guidelines for Americans. Am J Prev Med 2011; 40: 454-461.
25. Wang CY, Haskell WL, Farrell SW, et al,. Cardiorespiratory fitness levels among US adults 20-49 years of age: findings from the 1999-2004 National Health and Nutrition Examination Survey. Am J Epidemiol 2010; 171: 426-435.
26. Trost SG, Owen N, Bauman AE, et al,. Correlates of adults' participation in physical activity: review and update. Med Sci Sports Exerc 2002; 34: 1996-2001.
27. US Department of Health and Human Services (DHHS). 2008 Physical Activity Guidelines for Americans. Available at: http://www.health.gov/paguidelines/pdf/paguide.pdf
28. Gelfand JM, Gladman DD, Mease PJ, et al,. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53: 573.
29. Garg A, Gladman D,. Recognizing psoriatic arthritis in the dermatology clinic. J Am Acad Dermatol 2010; 63: 733-748; quiz 49-50.
30. Parsi KK, Brezinski EA, Lin TC, et al,. Are patients with psoriasis being screened for cardiovascular risk factors? A study of screening practices and awareness among primary care physicians and cardiologists. J Am Acad Dermatol 2012; 67: 357-362.
31. Pearce DJ, Stealey KH, Balkrishnan R, et al,. Psoriasis treatment in the United States at the end of the 20th century. Int J Dermatol 2006; 45: 370-374.
32. Frankel HC, Han J, Li T, et al,. The association between physical activity and the risk of incident psoriasis. Arch Dermatol 2012; 148: 918-924.
33. Soyland E, Heier I, Rodriguez-Gallego C, et al,. Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis. Br J Dermatol 2011; 164: 344-355.
34. Matz H,. Phototherapy for psoriasis: what to choose and how to use: facts and controversies. Clin Dermatol 2010; 28: 73-80.
35. Krueger G, Koo J, Lebwohl M, et al,. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001; 137: 280-284.
36. Wu Y, Mills D, Bala M,. Impact of psoriasis on patients' work and productivity: a retrospective, matched case-control analysis. Am J Clin Dermatol 2009; 10: 407-410.
37. Feldman SR, Fleischer AB Jr, Reboussin DM, et al,. The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 1996; 106: 183-186.
38. Kirby B, Richards HL, Woo P, et al,. Physical and psychologic measures are necessary to assess overall psoriasis severity. J Am Acad Dermatol 2001; 45: 72-76.
39. Poole L, Steptoe A, Wawrzyniak AJ, et al,. Associations of objectively measured physical activity with daily mood ratings and psychophysiological stress responses in women. Psychophysiology 2011; 48: 1165-1172.
40. Azevedo Da Silva M, Singh-Manoux A, Brunner EJ, et al,. Bidirectional association between physical activity and symptoms of anxiety and depression: the Whitehall II study. Eur J Epidemiol 2012; 27: 537-546.
41. Su YS, Yu HS, Li WC, et al,. Psoriasis as initiator or amplifier of the systemic inflammatory march: impact on development of severe vascular events and implications for treatment strategy. J Eur Acad Dermatol Venereol 2013; 27: 876-883.
42. Hjortsberg C, Bergman A, Bjarnason A, et al,. Are treatment satisfaction, quality of life, and self-assessed disease severity relevant parameters for patient registries? Experiences from Finnish and Swedish patients with psoriasis. Acta Derm Venereol 2011; 91: 409-414.
43. Kanelleas A, Liapi C, Katoulis A, et al,. The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept. Clin Exp Dermatol 2011; 36: 845-850.
44. Palota T, Szepietowski JC, Pec J, et al,. A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe. Acta Dermatovenerol Croat 2010; 18: 151-161.
45. Ragnarson Tennvall G, Hjortsberg C, Bjarnason A, et al,. Treatment patterns, treatment satisfaction, severity of disease problems, and quality of life in patients with psoriasis in three Nordic countries. Acta Derm Venereol 2013; 93: 442-445.
46. Root S, Kent G, al-Abadie MS,. The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis. Dermatology 1994; 189: 234-237.